Stannosis

From WikiMD's Medical Encyclopedia

Revision as of 07:21, 6 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Stannosis
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Cough, shortness of breath, chest pain
Complications Pulmonary fibrosis
Onset Gradual
Duration Long-term
Types N/A
Causes Inhalation of tin oxide dust
Risks Occupational exposure in tin processing industries
Diagnosis Chest X-ray, CT scan, Pulmonary function test
Differential diagnosis Silicosis, asbestosis, berylliosis
Prevention Use of protective equipment, ventilation systems
Treatment Symptomatic treatment, bronchodilators
Medication N/A
Prognosis Generally good if exposure is stopped
Frequency Rare
Deaths N/A


Occupational lung disease caused by inhalation of tin oxide dust


Stannosis is a type of pneumoconiosis, which is an occupational lung disease caused by the inhalation of dust. Specifically, stannosis results from the inhalation of tin oxide (SnO_) dust. It is considered a benign form of pneumoconiosis, as it does not typically lead to significant lung impairment or fibrosis.

Pathophysiology[edit]

Stannosis occurs when tin oxide particles are inhaled and deposited in the lungs. These particles are relatively inert and do not provoke a significant inflammatory response. As a result, the condition is often asymptomatic and does not progress to more severe forms of lung disease. The tin oxide particles can be visualized on chest X-rays as diffuse, small, rounded opacities, but these findings do not usually correlate with clinical symptoms.

Epidemiology[edit]

Stannosis is primarily an occupational disease, affecting workers who are exposed to tin oxide dust in industries such as mining, smelting, and manufacturing of tin-based products. The prevalence of stannosis has decreased in recent years due to improved occupational safety standards and the use of protective equipment.

Clinical Features[edit]

Most individuals with stannosis are asymptomatic. In cases where symptoms do occur, they are typically mild and may include:

  • Cough
  • Mild shortness of breath

However, these symptoms are not specific to stannosis and can be seen in a variety of other respiratory conditions.

Diagnosis[edit]

The diagnosis of stannosis is primarily based on occupational history and radiographic findings. A chest X-ray may reveal characteristic opacities, but these findings are not pathognomonic. A thorough occupational history is crucial to differentiate stannosis from other forms of pneumoconiosis.

Management[edit]

There is no specific treatment for stannosis, as it is generally a benign condition. Management focuses on prevention and minimizing exposure to tin oxide dust. This includes:

  • Implementing workplace safety measures
  • Using personal protective equipment (PPE)
  • Regular monitoring of workers' lung health

Prognosis[edit]

The prognosis for individuals with stannosis is excellent, as the condition does not typically lead to significant lung damage or functional impairment. With appropriate occupational safety measures, the risk of developing stannosis can be minimized.

Prevention[edit]

Preventive strategies are essential in reducing the incidence of stannosis. These include:

  • Engineering controls to reduce dust levels in the workplace
  • Use of respirators and other PPE
  • Regular health surveillance of workers

See also[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.